Project Grant R21DA061682
Award Date
7/15/25
Completion Date
6/30/27
Dollars Obligated
$426K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Louisiana, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded a $643,978 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to See Yourself Health LLC, a woman-owned small business in Beverly, MA. The grant titled "The CHIRON Project: Using Virtual Reality to Prevent Substance Use Disorder in Healthcare Workers Facing Burnout" aims to develop an immersive virtual reality platform that enables healthcare professionals to access confidential peer support, evidence-based...
The National Institute on Drug Abuse (NIDA) awarded a $959,964 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Charles River Analytics, Inc. to design and demonstrate the feasibility of a prototype system called Stimulant Use Recovery via Immersive Virtual Environments (SURVIVE). The goal of SURVIVE is to provide controlled environmental triggers and cognitive behavioral therapy (CBT) embedded into virtual environments to treat stimulant use disorder (STUD),...
The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $460,432 Project Grant to the Regents of the University of Minnesota to develop and pilot a comprehensive telehealth program at syringe service programs (SSPs) to engage people who inject drugs (PWID) into the HIV care continuum. The key products and services to be delivered include: Conducting formative research to understand determinants of HIV and addiction among...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,851,692 to the University of Illinois to conduct research on the effectiveness and implementation of a meditation app in addressing substance use, sexual health, and emotion regulation among justice-involved youth. The key products and services to be delivered under this 5-year award include: 1) Running a hybrid type 2...
This Project Grant award of $1,607,146.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a technology-based intervention to encourage drug checking, distribution of harm reduction supplies, and linkage to services for people who use drugs. The project, titled "Together Against Overdose: Community Developed Technology to Encourage Drug Checking, Distribution of Harm Reduction Supplies, and...
The National Institute on Drug Abuse (NIDA) awarded a $2,729,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Rhode Island. The purpose of this 2-year award, with a start date of September 15, 2024, is to rigorously develop and evaluate a mobile health intervention for adults with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential OUD treatment. The proposed mobile app...
This federal Project Grant award, with ID R01DA059503, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,192,612 grant will fund a 5-year research project by The Miriam Hospital, a non-profit healthcare and research institution in Providence, RI, to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives of this multidisciplinary research...
This Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and test a digital training tool called LEAPLINK. The LEAPLINK tool will help providers in housing, clinical, and social settings better support people with lived experience of homelessness and substance use disorder (PEH-SUD). Specifically, the $613,356 award will be used to co-develop the LEAPLINK prototype with PEH-SUD and a...
The National Institute on Drug Abuse (NIDA) awarded a Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $3,086,472 to the University of Rhode Island on September 15, 2024. The objective of this 5-year project is to evaluate the spillover effects of HIV interventions among marginalized populations, particularly young Black men who have sex with men (BMSM), who use illicit substances. The project will leverage data from three existing network studies in Chicago,...
This federal Project Grant award of $1,422,000 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is supporting the development and pilot testing of a mobile health (mHealth) intervention to reduce substance use and HIV risk among young adult women affected by sex trafficking. The project aims to adapt an existing mHealth intervention for this population, using qualitative and ecological momentary assessment methods to understand...